Mohammad Halim-Abdel

Cairo, C, Egypt

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications

An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020-present).

An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020-present).

Journal: Expert opinion on therapeutic patents
Published: June 23, 2026

Recent Advances in the Synthesis of Spiroindolines: Catalytic Strategies, Stereoselectivity, and Synthetic Utility (2020-2025).

Recent Advances in the Synthesis of Spiroindolines: Catalytic Strategies, Stereoselectivity, and Synthetic Utility (2020-2025).

Journal: Molecules (Basel, Switzerland)
Published: May 21, 2026

Lead-guided prodrug development of small molecules as GLP-1R agonists.

Lead-guided prodrug development of small molecules as GLP-1R agonists.

Journal: Bioorganic chemistry
Published: April 17, 2026

Benzothiophene nucleus in target-directed anti-cancer drug discovery.

Benzothiophene nucleus in target-directed anti-cancer drug discovery.

Journal: European journal of medicinal chemistry
Published: March 04, 2026

Small Molecules, Big Impact: Structural Innovations Driving PD-L1 Checkpoint Modulation.

Small Molecules, Big Impact: Structural Innovations Driving PD-L1 Checkpoint Modulation.

Journal: Archiv der Pharmazie
Published: February 15, 2026

Dual inhibition of neutrophil superoxide generation and elastase release via JNK, ERK and FAK pathways: blockade by methoxy-chalcone derivatives.

Dual inhibition of neutrophil superoxide generation and elastase release via JNK, ERK and FAK pathways: blockade by methoxy-chalcone derivatives.

Journal: RSC advances
Published: February 13, 2026

Pharmacokinetic assessment and metabolic stability of a novel multi-targeted Clk/Dyrk inhibitor using a validated LC-MS/MS method: In vitro and in vivo insights.

Pharmacokinetic assessment and metabolic stability of a novel multi-targeted Clk/Dyrk inhibitor using a validated LC-MS/MS method: In vitro and in vivo insights.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: October 12, 2025

Exploring pyrazolidinone and pyrazolidinedione scaffolds for Alzheimer's therapy: multitarget COX-2 inhibitors with anti-amyloid β, anti-tau, antioxidant, and neuroprotective activities.

Exploring pyrazolidinone and pyrazolidinedione scaffolds for Alzheimer's therapy: multitarget COX-2 inhibitors with anti-amyloid β, anti-tau, antioxidant, and neuroprotective activities.

Journal: RSC medicinal chemistry
Published: September 11, 2025

Development of a magnetic molecularly imprinted polymer for the removal of dexamethasone from river nile water.

Development of a magnetic molecularly imprinted polymer for the removal of dexamethasone from river nile water.

Journal: Scientific reports
Published: July 31, 2025

Revisiting COX-2 inhibitors for Alzheimer's disease as multitargeted ligands: Development of 4-hydrazono-pyrazolidinediones with tuned COX selectivity profile and improved cellular potency.

Revisiting COX-2 inhibitors for Alzheimer's disease as multitargeted ligands: Development of 4-hydrazono-pyrazolidinediones with tuned COX selectivity profile and improved cellular potency.

Journal: European journal of medicinal chemistry
Published: July 13, 2025

Design, synthesis and medical prospects of electrospun molecularly imprinted fibers.

Design, synthesis and medical prospects of electrospun molecularly imprinted fibers.

Journal: Scientific reports
Published: March 23, 2025

Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer.

Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer.

Journal: RSC medicinal chemistry
Published: January 26, 2025
Showing 1-12 of 75

Last Updated: 09/26/2026